An Adaptive Approach to Implementing Bivariate Group Sequential Clinical Trial Designs
From MaRDI portal
Publication:4430338
DOI10.1081/BIP-120024197zbMath1197.62153OpenAlexW2001828202WikidataQ47416519 ScholiaQ47416519MaRDI QIDQ4430338
Publication date: 7 October 2003
Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1081/bip-120024197
Applications of statistics to biology and medical sciences; meta analysis (62P10) Measures of association (correlation, canonical correlation, etc.) (62H20) Medical applications (general) (92C50) Sequential statistical design (62L05) Sequential statistical analysis (62L10)
Cites Work
- Discrete Sequential Boundaries for Clinical Trials
- Exact Confidence Intervals Following a Group Sequential Test
- Point and interval estimation following a sequential clinical trial
- Group Sequential Tests for Bivariate Response: Interim Analyses of Clinical Trials with Both Efficacy and Safety Endpoints
- Group-Sequential Analysis Incorporating Covariate Information
- Semiparametric Efficiency and Its Implication on the Design and Analysis of Group-Sequential Studies
- Treatment Comparisons Based on Two‐Dimensional Safety and Efficacy Alternatives in Oncology Trials
- Design and analysis of group sequential tests based on the type I error spending rate function
- Evaluation of Experiments with Adaptive Interim Analyses
- Guidelines for Monitoring Efficacy and Toxicity Responses in Clinical Trials
- Nonparametric sequential testing in clinical trials with incomplete multivariate observations
This page was built for publication: An Adaptive Approach to Implementing Bivariate Group Sequential Clinical Trial Designs